9/13 MannKind: Their Technosphere Drug Delivery System - Hope Or Hype? •A business model creating a cost of more than 9 times the money generated with each prescription being sold. •A constantly changing business model for how they will expand their product pipeline. •Merely hoping a word change on a drug label will alter the inherent flaw in their product. •Nearly out of operating funds and they pick a fight with a company with massive cash on hand and a market cap of $5.0 Billion. https://seekingalpha.com/article/4106439-mannkind-technosphere-drug-delivery-system-hope-hype?auth_param=1vat:1crid91:f776fa780b1dc7ddf297e354fa812b62&uprof=51#alt1